当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析 - 现金流量表

迈普医学

(301033)

  

流通市值:30.21亿  总市值:35.94亿
流通股本:5638.68万   总股本:6708.27万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金206,831,959.693,575,718.62401,608,194.11279,703,271.51
  收到的税费返还--1,066,476.67342,635.58
  收到其他与经营活动有关的现金3,390,308.741,010,502.3412,056,406.35,835,349.97
  经营活动现金流入小计210,222,268.3494,586,220.96414,731,077.08285,881,257.06
  购买商品、接受劳务支付的现金35,499,338.6821,510,286.9457,071,846.7835,573,601.32
  支付给职工以及为职工支付的现金65,147,774.4837,993,484.198,752,712.6768,917,119.33
  支付的各项税费24,521,868.1413,926,775.0849,686,739.334,060,786.81
  支付其他与经营活动有关的现金36,850,699.1317,953,449.8469,353,099.7663,571,561.04
  经营活动现金流出小计162,019,680.4391,383,995.96274,864,398.51202,123,068.5
  经营活动产生的现金流量净额48,202,587.913,202,225139,866,678.5783,758,188.56
二、投资活动产生的现金流量:
  收回投资收到的现金258,365,246.45123,034,078.62560,349,186.13475,217,471.23
  取得投资收益收到的现金92,63062,790--14,650
  处置固定资产、无形资产和其他长期资产收回的现金净额--80,825.9450,766.92
  投资活动现金流入小计258,457,876.45123,096,868.62560,430,012.07475,253,588.15
  购建固定资产、无形资产和其他长期资产支付的现金21,018,607.57,917,432.8523,819,716.817,915,776.23
  投资支付的现金216,807,24175,976,062682,225,852524,985,192
  投资活动现金流出小计237,825,848.583,893,494.85706,045,568.8542,900,968.23
  投资活动产生的现金流量净额20,632,027.9539,203,373.77-145,615,556.73-67,647,380.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金--12,626,905.0512,955,659.6
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--12,626,905.0512,955,659.6
  分配股利、利润或偿付利息支付的现金46,765,485.9-39,700,158.639,696,972.91
  支付其他与筹资活动有关的现金12,720-1,122,214.95956,920.1
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计46,778,205.9-40,822,373.5540,653,893.01
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-46,778,205.9--28,195,468.5-27,698,233.41
四、汇率变动对现金及现金等价物的影响-648,129.59-360,776.12321,959.72476,542.53
五、现金及现金等价物净增加额21,408,280.3742,044,822.65-33,622,386.94-11,110,882.4
  加:期初现金及现金等价物余额19,595,214.3319,595,214.3353,217,601.2753,217,601.27
  期末现金及现金等价物余额41,003,494.761,640,036.9819,595,214.3342,106,718.87
补充资料:
  净利润56,580,533.57-113,128,438.52-
  资产减值准备1,006,631.93-2,877,417.21-
  固定资产和投资性房地产折旧9,102,148.15-18,549,801.21-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,102,148.15-18,549,801.21-
  无形资产摊销4,156,733.66-8,136,198.17-
  长期待摊费用摊销199,261.76-572,942.03-
  处置固定资产、无形资产和其他长期资产的损失---6,437.07-
  固定资产报废损失-69,694.2-2,697,376.44-
  公允价值变动损失-291,865.26--185,028.55-
  财务费用671,470.49--727,437.27-
  投资损失-1,711,902.97--2,938,077.08-
  递延所得税-164,385.77-97,826.88-
  其中:递延所得税资产减少-1,616,430.4-108,179.18-
    递延所得税负债增加1,452,044.63--10,352.3-
  存货的减少-6,898,097.03--5,287,744.67-
  经营性应收项目的减少-5,350,751.5--3,934,790.29-
  经营性应付项目的增加-9,335,890.08--3,407,332.82-
  其他--9,485,037.21-
  现金的期末余额41,003,494.7-19,595,214.33-
  减:现金的期初余额19,595,214.33-53,217,601.27-
  现金及现金等价物的净增加额21,408,280.37--33,622,386.94-
公告日期2026-08-212026-04-282026-04-282025-10-24
审计意见(境内)标准无保留意见
TOP↑